Tower Research Capital (TRC)’s KALA BIO KALA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.07K | Buy |
+616
| New | +$2.99K | ﹤0.01% | 4895 |
|
|
2025
Q4 | – | Sell |
-102
| Closed | -$7.77K | – | 5398 |
|
|
2025
Q3 | $7.77K | Buy |
102
+79
| +343% | +$39.2K | ﹤0.01% | 4081 |
|
|
2025
Q2 | $5.44K | Buy |
23
+19
| +475% | +$3.71K | ﹤0.01% | 4192 |
|
|
2025
Q1 | $1.27K | Sell |
4
-10
| -71% | -$3.79K | ﹤0.01% | 4745 |
|
|
2024
Q4 | $4.94K | Sell |
14
-1
| -7% | -$315 | ﹤0.01% | 4374 |
|
|
2024
Q3 | $4.3K | Sell |
15
-22
| -59% | -$6.94K | ﹤0.01% | 4599 |
|
|
2024
Q2 | $13.2K | Buy |
37
+5
| +16% | +$1.65K | ﹤0.01% | 3992 |
|
|
2024
Q1 | $12.9K | Sell |
32
-55
| -63% | -$20.4K | ﹤0.01% | 3434 |
|
|
2023
Q4 | $30.5K | Buy |
+87
| New | +$30.8K | ﹤0.01% | 3414 |
|
|
2023
Q3 | – | Sell |
-3
| Closed | -$2.42K | – | 6098 |
|
|
2023
Q2 | $2.42K | Sell |
3
-17
| -85% | -$13.2K | ﹤0.01% | 5201 |
|
|
2023
Q1 | $15K | Buy |
20
+18
| +900% | +$15.7K | ﹤0.01% | 3791 |
|
|
2022
Q4 | $3K | Sell |
2
-14
| -88% | -$5.54K | ﹤0.01% | 5200 |
|
|
2022
Q3 | $9K | Buy |
+16
| New | +$12.6K | ﹤0.01% | 4662 |
|
|
2022
Q2 | – | Sell |
-5
| Closed | -$16K | – | 6309 |
|
|
2022
Q1 | $16K | Sell |
5
-10
| -67% | -$26.2K | ﹤0.01% | 3757 |
|
|
2021
Q4 | $46K | Buy |
15
+14
| +1,400% | +$65K | ﹤0.01% | 2823 |
|
|
2021
Q3 | $9K | Sell |
1
-3
| -75% | -$25.9K | ﹤0.01% | 4447 |
|
|
2021
Q2 | $49K | Buy |
4
+3
| +300% | +$47.2K | ﹤0.01% | 3041 |
|
|
2021
Q1 | $25K | Sell |
1
-5
| -83% | -$97.6K | ﹤0.01% | 3706 |
|
|
2020
Q4 | $99K | Sell |
6
-10
| -63% | -$188K | ﹤0.01% | 2353 |
|
|
2020
Q3 | $305K | Buy |
16
+14
| +700% | +$322K | ﹤0.01% | 2173 |
|
|
2020
Q2 | $54K | Buy |
+2
| New | +$56.7K | ﹤0.01% | 2980 |
|
|
2020
Q1 | – | Sell |
-5
| Closed | -$45K | – | 3491 |
|
|
2019
Q4 | $45K | Buy |
5
+3
| +150% | +$29K | ﹤0.01% | 1408 |
|
|
2019
Q3 | $16K | Buy |
+2
| New | +$24.3K | ﹤0.01% | 2614 |
|
|
2019
Q2 | – | Hold |
0
| – | -$4K | – | 3983 |
|
|
2019
Q1 | – | Sell |
-1
| Closed | -$17.8K | – | 3174 |
|
|
2018
Q4 | $14K | Buy |
+1
| New | +$17.3K | ﹤0.01% | 2211 |
|
|
2018
Q3 | – | Hold |
0
| – | -$4K | – | 4012 |
|
|
2018
Q2 | – | Hold |
0
| – | – | – | 3137 |
|
|
2018
Q1 | – | Hold |
0
| – | -$21K | – | 3562 |
|
|
2017
Q4 | – | Hold |
0
| – | – | – | 2027 |
|
|
2017
Q3 | – | Hold |
0
| – | – | – | 2886 |
|
Other funds holding KALA
Tower Research Capital (TRC)'s KALA Position: Q2 2026 in Review
Tower Research Capital (TRC) opened a new position in KALA BIO (KALA) in Q2 2026: 616 shares worth $1.07K. The stake represents ﹤0.01% of the portfolio and ranks #4895 among its holdings. This is a return to the name: Tower Research Capital (TRC) previously reported a position in KALA as recently as Q3 2025.
Tower Research Capital (TRC) first reported a position in KALA in Q4 2018 and has held it in 24 quarters since. The position peaked at $305K in Q3 2020. 14 funds tracked by Wall St. Rank hold KALA as of Q2 2026.
- Tower Research Capital (TRC) held 616 shares of KALA BIO worth $1.07K as of Q2 2026.
- KALA BIO was a new Tower Research Capital (TRC) position in Q2 2026.
- KALA BIO made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q2 2026, its #4895 holding.
- Tower Research Capital (TRC) first reported a position in KALA BIO in Q4 2018 and has held it in 24 quarters since.
- Tower Research Capital (TRC)'s KALA BIO position peaked at $305K in Q3 2020.
- 14 funds tracked by Wall St. Rank held KALA BIO as of Q2 2026.
Based on Tower Research Capital (TRC)'s 13F filing for Q2 2026, filed 11 Aug 2026.